OPTN – optinose, inc. (US:NASDAQ)
Stock Stats
News
OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million [Yahoo! Finance]
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
OptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years ago [Yahoo! Finance]
Optinose to Present at the Needham Virtual Healthcare Conference
Form DEFA14A OptiNose, Inc.
Form DEF 14A OptiNose, Inc. For: Dec 31
Form SC 13G/A OptiNose, Inc. Filed by: Rosalind Advisors, Inc.
Form 8-K OptiNose, Inc. For: Apr 25
Form 4 OptiNose, Inc. For: Mar 18 Filed by: Krick Anthony J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.